17 others would like to attend.
Register Now
550 1st Ave., New York, NY 10016, United States
Event info
OVERVIEW
This novel interdisciplinary symposium will be provided as a virtual and in-person learning experience for an update on Asthma, COPD, and Environmental interactions that contribute to airway diseases for medical providers, nurses, and environmental scientists. The course will be presented as a one-day session with lectures using both synchronous and asynchronous learning techniques. Course material will include a basic overview of lung toxicity from environmental exposures to man-made pollutants, climate change, and social determinants of health. We will discuss the impact of comorbidities and health disparities on airway diseases. We will include new tools for assessing disease severity and a discussion of mechanisms of severe and difficult-to-treat asthma and COPD with the goal toward optimization of personalized treatment approaches. At the end of this symposium, the participant will have improved expertise in asthma and COPD management involving new therapeutics and environmental modifications.
LEARNING OBJECTIVES
After participating in this activity, clinicians should be able to:
- Discuss the role of climate change on incidence/prevalence and severity of airway disease, recognize the contribution of environmental exposures, social determinants of health, comorbid conditions, and how to use new therapeutic interventions in the context of these issues
- Describe the contribution of social disparities, violence and elevated body mass on asthma and COPD severity
- Identify interventions to mitigate severity of disease and reduce adverse outcomes from therapy
- Identify ways in which man-made and natural environmental exposures can affect the airway and ways in which we can measure these effects in asthma and COPD using available clinical and digital tools, as well as physiologic measures
- Discuss the approaches to the use of as-needed inhaled corticosteroids management of asthma symptoms as well as phenotypes in asthma and how we use those to choose new treatments, including biologic agents, for asthma
TARGET AUDIENCE
Pulmonary Specialists, Internists, Pulmonary Fellows, Medical Residents, Nurse Practitioners, Nurses, Nursing Students, Environmental and Population Health Scientists
ACCREDITATION
The NYU Grossman School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The NYU Grossman School of Medicine designates this live activity for a maximum of 7.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
For more information please visit the official event page.
Faculty
-
Joan Reibman
Course Director
-
Gail Schattner
Course Director
Course Syllabus
Click HERE to view the syllabus
17 others would like to attend.
Register Now